Setbacks put drug firms under pressure

The pharmaceuticals sector was under pressure today after high-profile setbacks for AstraZeneca and GlaxoSmithKline spooked investors.

Setbacks put drug firms under pressure

The pharmaceuticals sector was under pressure today after high-profile setbacks for AstraZeneca and GlaxoSmithKline spooked investors.

Shares in AstraZeneca plunged more than 8% after it ditched experimental stroke drug NXY-059 following its failure during clinical trials.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited